Purchase Order HT941023P0159
Award Date
8/22/23
Potential Completion Date
9/30/24
Potential Value
$255K
Federal Agency
Defense Health Agency
Awardee
Fenwal, Inc.
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Defense Health Agency Contracting Activity (DHACA) to Fenwal, Inc., a global blood technology company, for the annual supply of Fenwal Amicus Apheresis kits, reagents, and consumables in support of the U.S. Naval Hospital Okinawa (USNHO) in Japan. The total contract value is $66,275.04 with a completion date of July 1, 2025. This is a firm fixed-price purchase order contract, as Fenwal is the sole manufacturer and proprietor of the required Amicus-specific...
This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
This is a firm fixed price (FFP) purchase order awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products and equipment. The $220,180.33 contract has a base period plus three one-year option periods to provide the following deliveries annually: 60 cases of 12% sodium chloride solution, 1 case of Sepacell pre-storage leukocyte reduction products, 88 cases of Amicus apheresis kits, and 24 cases of Intersol solution. The requirement had...
This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and a subsidiary of Fresenius Kabi. The $1,569.00 contract is for the delivery of various blood collection, separation, storage, and transfusion products, including blood bags, tubing, diluting solutions, washing solutions, anticoagulants, extractors, sealers, clips, stands, and transfer sets. Fenwal, Inc. has an extensive...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for annual preventative maintenance services on AMICUS blood separators, with a ceiling value of $129,894.02 and a period of performance through June 10, 2027. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government, having secured multiple...
This federal contract award from the Defense Logistics Agency (DLA) is for the provision of blood collection supplies to support medical and healthcare initiatives. The $5,743.25 firm-fixed-price purchase order was awarded to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection, separation, storage, and transfusion products and services. The contract has a performance period ending on March 26, 2025 and does not include a set-aside designation. Fenwal, Inc. is a key...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $23,250.90 contract is for the delivery of COMPOSEAL MOBILEA II SET, a medical supply item. The contract does not have a set-aside designation. Fenwal, which has been a registered federal vendor since 2007, has established itself as a key supplier of a diverse array of products and services to support critical...
This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...
This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $3,347.76 contract is for the delivery of washing solution, FR (federal supply code 8510539296), with a completion date of June 3, 2024. Fenwal, Inc. has an extensive history of providing blood collection, separation, storage, and transfusion products and services to various federal agencies, including the Department of...